The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation
The DOI matches its Crossref record, with a small difference in title or year; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background Diabetes mellitus is recognized as a stroke risk factor in atrial fibrillation (AF). Patients with diabetes with retinopathy have an increased risk for systemic cardiovascular complications, and severe diabetic retinopathy predisposes to ocular bleeding. We hypothesized that patients with diabetes, retinopathy, and AF have increased stroke/thromboembolism (TE) and severe bleeding risks when compared with patients with diabetes and AF who do not have retinopathy or to patients with AF and without diabetes.Methods We tested our hypothesis in a large "real-world" cohort of individuals with AF from the Loire Valley Atrial Fibrillation project.Results Of 8,962 patients with AF in our dataset, 1,409 (16%) had documented diabetes mellitus. Of these, 163 (1.8% of the whole cohort) were patients with diabetic retinopathy. After a follow-up of 31 ± 36 months, when compared with patients without diabetes, the risk of stroke/TE in patients with diabetes with no retinopathy increased 1.3-fold (relative risk [RR], 1.30; 95% CI, 1.07-1.59; P = .01); in patients with diabetes with retinopathy, the risk of stroke/TE was increased 1.58-fold (RR, 1.58; 95% CI, 1.07-2.32; P = .02). There was no significant difference when patients with diabetes with no retinopathy were compared with patients with diabetes with retinopathy (RR, 1.21; 95% CI, 0.80-1.84; P = .37). A similar pattern was seen for mortality and severe bleeding. On multivariate analysis, the presence of diabetic retinopathy did not emerge as an independent predictor for stroke/TE or severe bleeding.Conclusions Crude rates of stroke/TE increased in a stepwise fashion when patients without diabetes and with AF were compared with patients with diabetes with no retinopathy and patients with diabetes with retinopathy. However, we have shown for the first time, to our knowledge, that the presence of diabetic retinopathy did not emerge as an independent predictor for stroke/TE or severe bleeding on multivariate analysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The beneficial efficacy and safety of NOACs compared with warfarin seem conserved in patients with AF and diabetes, irrespective of their baseline stroke risk or the presence of other CV risk factors.577,[627][628][629]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [628]
In the citing paper
“Diabetic retinopathy, a measure of disease severity, does not increase the risk of ocular bleeding in anticoagulated patients.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [287]
Citations
Cites
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citationGage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
Self-citation(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Huxley, R. R., Filion, K. B., Konety, S., & Alonso, A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.004 · Cited by 561
Rising Rates of Hospital Admissions for Atrial Fibrillation
Friberg, J., Buch, P., Scharling, H., Gadsbøll, N., & Jensen, G. B. (2003) · Epidemiology · doi:10.1097/01.ede.0000091649.26364.c0 · Cited by 287
Confounding by Indication in Epidemiologic Studies of Commonly Used Analgesics
Signorello, L. B., McLaughlin, J. K., Lipworth, L., Friis, S., S??rensen, H. T., & Blot, W. J. (2002) · American Journal of Therapeutics · doi:10.1097/00045391-200205000-00005 · Cited by 178
Effect of hypertension on anticoagulated patients with atrial fibrillation
Lip, G. Y. H., Frison, L., Grind, M., & on behalf of the SPORTIF Investigators (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl504 · Cited by 168
Self-citationPisters, R., Lane, D. A., Marin, F., Camm, A. J., & Lip, G. Y. H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1036 · Cited by 159
Self-citationStroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
Lip, G. Y. H. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs435 · Cited by 157
Self-citationRenal Impairment and Ischemic Stroke Risk Assessment in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.035 · Cited by 124
Self-citationType 2 diabetes mellitus and risk of incident atrial fibrillation in women
Schoen, T., Pradhan, A. D., Albert, C. M., & Conen, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.030 · Cited by 106
Cui, R., Iso, H., Yamagishi, K., Saito, I., Kokubo, Y., Inoue, M., & Tsugane, S. (2011) · Stroke · doi:10.1161/strokeaha.111.614313 · Cited by 86
Mostaza, J. M., Suárez, C., Manzano, L., Cairols, M. A., López-Fernández, F., Aguilar, I., Lois, F. D., Sampedro, J. L., Sánchez-Huelva, H., Sanchez-Zamorano, M. A., et al. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.06.018 · Cited by 44
Olive, M. F., Gomez, F., Schott, A., Remontet, L., Bossard, N., Mitton, N., Polazzi, S., Colonna, M., & Trombert‐Paviot, B. (2011) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2010.09.001 · Cited by 36
Ricardo, A. C., Grunwald, J. E., Parvathaneni, S., Goodin, S., Ching, A., & Lash, J. P. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.437 · Cited by 35
Clinical Factors Associated With the Diagnosis and Progression of Diabetic Nephropathy
Liang, S., Li, Q., Zhu, H., Zhou, J., Ding, R., Chen, X., & Cai, G. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9892-9 · Cited by 21
Lopes, L. C., Spencer, F. A., Neumann, I., Ventresca, M., Ebrahim, S., Zhou, Q. X., Bhatnagar, N., Schulman, S., Eikelboom, J. W., & Guyatt, G. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088131 · Cited by 21
Pfister, R., Michels, G., Cairns, R., Schneider, C. A., & Erdmann, E. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.049 · Cited by 15
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citation2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Self-citation
Metadata
- Authors
- Lip, G. Y. H., Clementy, N., Pierre, B., Boyer, M., & Fauchier, L.
- Affiliations
- Birmingham City Hospital (GB)
- Université de Tours (FR)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 147
- Issue
- 4
- Pages
- 1103-1110
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2138362116
- Cited by
- 26
- References
- 19
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 6 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 1
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Funders
- International Business Machines Corporation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- diabetic retinopathy, atrial fibrillation, stroke, thromboembolism, major bleeding, diabetes mellitus, cardiovascular risk, mortality
- MeSH terms
- Aged, Atrial Fibrillation, Diabetes Mellitus, Diabetic Retinopathy, Female, Follow-Up Studies, France, Hemorrhage, Humans, Male, Morbidity, Prognosis, Retrospective Studies, Risk Factors, Severity of Illness Index, Survival Rate, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.